Filter By Category
Archives
Share on -
ANDUSOMERAN
Generic Name: ANDUSOMERAN
ABSTRACT -
Andusomeran is a nucleoside-modified messenger RNA vaccine active substance encoding a SARS-CoV-2 spike antigen for XBB.1.5-lineage COVID-19 vaccine formulations. The mRNA is formulated in lipid nanoparticles and is translated by host cells to trigger protective immune responses against COVID-19.
DOSAGE -
- Dosage should be determined according to the current national immunization schedule and product label.
- Administration is by intramuscular injection by trained healthcare personnel.
- Dose, age eligibility, booster timing, and variant formulation can change by country and season.
- Patients should be observed after vaccination according to local guidance for immediate reactions.
SIDE EFFECTS–
- Possible side effects include:
- Injection-site pain, redness, or swelling
- Fatigue
- Headache
- Myalgia
- Chills
- Fever
- Lymphadenopathy
- Nausea
- Rare myocarditis or pericarditis, especially in younger males after mRNA vaccination
ALLRGIC REACTIONS–
- Possible allergic reaction symptoms include:
- Urticaria
- Facial or throat swelling
- Wheezing
- Severe dizziness
- Anaphylaxis
- Important: Patients who develop an allergic reaction to Andusomeran should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS–
- Immunosuppressive therapy may reduce vaccine response.
- Other vaccines may be co-administered only according to national guidance.
- Anticoagulants or bleeding disorders require injection-site precautions.
- Prior severe allergic reaction to vaccine components is a key contraindication or precaution.
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Screen for prior anaphylaxis to vaccine ingredients and prior myocarditis/pericarditis after mRNA vaccination.
- Defer vaccination during acute moderate or severe illness when advised.
- Observe patients with allergy history for the recommended post-vaccination period.
- Report serious adverse events through local vaccine-safety systems.
WARNINGS –
- Severe allergic reactions require immediate emergency treatment.
- Seek medical care for chest pain, shortness of breath, palpitations, or fainting after vaccination.
- Use only formulations authorized for the patient age group and season.
- Keep out of reach of children.
Share on -
. Developed by